Health
Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis – News-Medical.Net
A new study examines the associations between immunosuppressive disease-modifying therapies (DMTs) used in MS with adverse outcomes in an international cohort of…
In the ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), patients with coexisting medical conditions have been noted to be at a higher risk of progressive and severe disease. Patients with multiple sclerosis (MS), who are often on immunosuppressive therapy, may be among these high-risk groups.
A new study, released on the medRxiv* preprint server, examines the associations between immunosuppressive disease-modifying…
-
Noosa News23 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General19 hours ago‘Potential’ hacker contacts Qantas over data breach
-
General24 hours agoReflections from a broken Europe
-
Business9 hours agoFord CEO makes stunning prediction about artificial intelligence